Agnogenic Myeloid Metaplasia

Also known as: Myelofibrosis / Myelosis non-leukemic / Myelosis-non-leukaemic / Myelosis non-leukaemic / Myelosis nonleukemic / Myelofibrosis NOS

DrugDrug NameDrug Description
DB06412OxymetholoneOxymetholone is a synthetic anabolic steroid marketed under the brand name Anapolon by Hoffmann La Roche Limited. Its primary clinical applications include treatment of osteoporosis and anaemia, as well as stimulating muscle growth in malnourished or underdeveloped patients. Anabolic-androgenic steroids (AAS), such as oxymetholone, have been abused by bodybuilders and athletes. The uncontrolled misuse of oxymetholone can lead to a large variety of detrimental effects, the most often reported of which are cardiovascular events. In 2009, no producers of oxymetholone were identified worldwide (SRI 2009), but it was available from 14 suppliers, including 8 U.S. suppliers (ChemSources 2009).
DrugDrug NamePhaseStatusCount
DB01169Arsenic trioxide0Completed1
DB00987Cytarabine0Completed1
DB09036Siltuximab0Withdrawn1
DB09312Antilymphocyte immunoglobulin (horse)1Recruiting1
DB00098Antithymocyte immunoglobulin (rabbit)1Recruiting2
DB00928Azacitidine1Completed1
DB01008Busulfan1Recruiting3
DB00631Clofarabine1Unknown Status1
DB09110Coenzyme M1Recruiting1
DB00531Cyclophosphamide1Recruiting1
DB00531Cyclophosphamide1Unknown Status1
DB01262Decitabine1Not Yet Recruiting1
DB06165Fedratinib1Completed1
DB00099Filgrastim1Recruiting1
DB01073Fludarabine1Recruiting4
DB12396Fresolimumab1Terminated1
DB13040Gandotinib1Completed1
DB09054Idelalisib1Completed1
DB01042Melphalan1Recruiting1
DB00563Methotrexate1Recruiting2
DB00688Mycophenolate mofetil1Recruiting1
DB01024Mycophenolic acid1Recruiting1
DB11697Pacritinib1Completed2
DB11697Pacritinib1Not Yet Recruiting1
DB11730Ribociclib1Recruiting1
DB08877Ruxolitinib1Completed2
DB08877Ruxolitinib1Recruiting3
DB08877Ruxolitinib1Terminated1
DB12756TAK-9011Completed1
DB00864Tacrolimus1Recruiting2
DB04572Thiotepa1Recruiting1
DB08828Vismodegib1Terminated1
DB05243XL0191Terminated1
DB05169AT92831 / 2Terminated1
DB11703Acalabrutinib1 / 2Recruiting1
DB01590Everolimus1 / 2Completed1
DB06165Fedratinib1 / 2Completed1
DB12500Fedratinib1 / 2Completed1
DB00619Imatinib1 / 2Completed1
DB00688Mycophenolate mofetil1 / 2Recruiting1
DB11697Pacritinib1 / 2Completed2
DB06603Panobinostat1 / 2Active Not Recruiting1
DB00008Peginterferon alfa-2a1 / 2Recruiting1
DB09037Pembrolizumab1 / 2Recruiting1
DB08877Ruxolitinib1 / 2Active Not Recruiting2
DB08877Ruxolitinib1 / 2Recruiting1
DB00877Sirolimus1 / 2Recruiting1
DB04879Vatalanib1 / 2Completed1
DB00087Alemtuzumab2Completed1
DB09312Antilymphocyte immunoglobulin (horse)2Recruiting1
DB00098Antithymocyte immunoglobulin (rabbit)2Completed1
DB00098Antithymocyte immunoglobulin (rabbit)2Recruiting1
DB00928Azacitidine2Completed1
DB00074Basiliximab2Completed1
DB00112Bevacizumab2Terminated1
DB00188Bortezomib2Recruiting1
DB01008Busulfan2Completed2
DB00958Carboplatin2Not Yet Recruiting1
DB00493Cefotaxime2Not Yet Recruiting1
DB00493Cefotaxime2Recruiting2
DB00531Cyclophosphamide2Not Yet Recruiting1
DB00531Cyclophosphamide2Recruiting5
DB00091Cyclosporine2Recruiting2
DB01254Dasatinib2Completed1
DB06210Eltrombopag2Active Not Recruiting1
DB12500Fedratinib2Completed1
DB00099Filgrastim2Recruiting1
DB01073Fludarabine2Completed1
DB01073Fludarabine2Not Yet Recruiting1
DB01073Fludarabine2Recruiting4
DB00619Imatinib2Completed1
DB12154Itacitinib2Recruiting1
DB00480Lenalidomide2Active Not Recruiting1
DB00480Lenalidomide2Completed1
DB01042Melphalan2Completed1
DB01042Melphalan2Recruiting1
DB00688Mycophenolate mofetil2Recruiting3
DB12191Obatoclax2Completed1
DB05829Parathyroid hormone2Terminated1
DB00008Peginterferon alfa-2a2Terminated1
DB04977Plitidepsin2Completed1
DB08910Pomalidomide2Completed1
DB00635Prednisone2Active Not Recruiting1
DB00635Prednisone2Completed1
DB12146Rigosertib2Recruiting1
DB08877Ruxolitinib2Active Not Recruiting1
DB08877Ruxolitinib2Completed2
DB08877Ruxolitinib2Recruiting3
DB12152Simtuzumab2Completed1
DB00864Tacrolimus2Recruiting2
DB06285Teriparatide2Terminated1
DB01041Thalidomide2Recruiting1
DB01030Topotecan2Not Yet Recruiting1
DB07232Veliparib2Not Yet Recruiting1
DB00399Zoledronic acid2Completed1
DB01609Deferasirox3Completed1
DB13900Equine Botulinum Neurotoxin A Immune FAB23Completed1
DB13903Equine Botulinum Neurotoxin B Immune FAB23Completed1
DB13898Equine Botulinum Neurotoxin C Immune FAB23Completed1
DB13902Equine Botulinum Neurotoxin D Immune FAB23Completed1
DB13897Equine Botulinum Neurotoxin E Immune FAB23Completed1
DB13901Equine Botulinum Neurotoxin F Immune FAB23Completed1
DB13899Equine Botulinum Neurotoxin G Immune FAB23Completed1
DB08877Ruxolitinib3Completed2
DB08877Ruxolitinib4No Longer Available1
DB05220AlisertibNot AvailableRecruiting1
DB00098Antithymocyte immunoglobulin (rabbit)Not AvailableCompleted1
DB00074BasiliximabNot AvailableTerminated1
DB01008BusulfanNot AvailableCompleted1
DB01008BusulfanNot AvailableWithdrawn1
DB00493CefotaximeNot AvailableRecruiting1
DB00531CyclophosphamideNot AvailableRecruiting2
DB00531CyclophosphamideNot AvailableTerminated1
DB00091CyclosporineNot AvailableRecruiting2
DB00091CyclosporineNot AvailableTerminated1
DB00099FilgrastimNot AvailableWithdrawn1
DB01073FludarabineNot AvailableCompleted1
DB01073FludarabineNot AvailableRecruiting2
DB01073FludarabineNot AvailableTerminated1
DB01042MelphalanNot AvailableCompleted1
DB00688Mycophenolate mofetilNot AvailableRecruiting2
DB00688Mycophenolate mofetilNot AvailableTerminated1
DB08877RuxolitinibNot AvailableWithdrawn1
DB00864TacrolimusNot AvailableRecruiting1